ENLV
NASDAQ
$4.64
Enlivex Ltd (ENLV)
Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Target: $300 (+6365.52%)
Market Cap
$92M
P/B Ratio
0.05
P/E Ratio
0.07
Free Cash Flow Yield
-11.34%
Price Chart
Valuation
Market Cap$92M
P/E0.07
P/B0.05
Profitability
EBITDA-$15M
EPS$78.03
Financial Health
Free Cash Flow Yield-11.34%
Growth & Risk
Beta (5Y)1.02
Sharpe Ratio-1.24